Purespring Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$104.8M

Purespring Therapeutics is a gene therapy company specializing in developing treatments for kidney diseases using a proprietary adeno-associated viral (AAV) platform.

Total Funding

$104.8M

Headquarters

London, United Kingdom

Founded

N/A

Website

purespringtx.com

Focus Areas

Gene therapy

Kidney diseases

Adeno-associated viral platform

Renal diseases

Clinical trial

IgA Nephropathy

Investors